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Introduction
Limbal stem cells (LSC) have the function of regenerating
corneal epithelial cells, as well as maintaining the
integrity of the corneal epithelium. Various ocular
pathologies can affect the limbal region, causing lymbal
stem cell dysfunction (LSCD). All cases of moderate to
severe LSCD require surgical management. The main
directions of its surgical treatment are: direct limbal
tissue transplantation and ex vivo/in vivo expanded LSC
transplantation. The amniotic membrane (AM), used
alone or as a substrate for LSC, can be incorporated into
LSC transplantation in almost all surgical approaches.
Purpose
To analyze the current data on applications of AM in the
surgical management of limbal stem cell deficiency and to
summarize the results of various surgical approaches.
Material and methods
A systematic search was performed on PubMed for papers
published until February 2020, using combinations of the
following search terms: "amniotic membrane", "limbal
stem cell deficiency", "limbal transplantation",
"conjunctival limbal auto-/allograft", ” keratolimbal
allograft”. The data on AM preparation, as well as surgical
techniques and clinical results was collected and
analyzed.
Results
1. Isolated AM transplantation (AMT)
We selected 7 studies that reported results of isolated
AMT in the treatment of partial LSCD (Table 1). Stable
epithelial surface was maintained during a period of 12-
25 months after surgery. Nonetheless, the success rate of
AMT alone in patients with LSCD was only 31% at over a
50 months follow-up period.
Conclusions
Preliminary results of the application of AM in limbal
transplantation show quite satisfactory data, but the lack
of high-level studies, such as randomized controlled
clinical trials, make it difficult to assess the comparative
efficacy of AM transplantation in the surgical management
of LSCD. And although studies have consistently reported
favorable outcomes of different LSC transplantation
techniques combined with AMT, it is unclear at the
moment what is the role of the AM specifically and to
what extent it impacts the final result.
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2015 Chugh JP 30 48.9 2 - 6
2013 Konomi K 16 57.4 1.5 31.2 52.3
2008 Kheirkhah A 11 32.4 2.5 72.7 14.2
2005 Lopez-Garcia 
JS
14 37 2 - 24
2005 Ivekovic R 5 31.6 3 60 18
2003 Gomes JA 4 34.5 3 - 17.5
2001 Anderson DF 17 42.3 2.5 58.8 25.8
Table 1. Outcomes of AMT alone in patients with LSCD
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2017 Arora R 10 18 2.5 90 6
2015 Moreira PB 28 40.3 4 - 24.8
2014 Barreiro TP 15 36.3 2 73.3 19.7
2012 Baradaran-
Rafii
34 27.3 3.5 - 17.2
2012 Eberwein P 20 44 1.5 - 22.4
2011 Han ES 24 39.4 4 66.6 47.3
Table 2. Outcomes of AMT+CLAU/CLAL in patients 
with LSCD
3. Transplantation of ex vivo expanded LSC on AM
A total of 23 studies were selected for the analysis of the
outcome of CLET and COMET combined with AM
substrate. The rejection rate of CLET was relatively low
even when allogenic tissue was used, thanks to the small
size of transplanted tissue, and the rate of success was
stable even after one year. Similarly, the successful rate of
COMET was stable two years after surgery.
2. Transplantation of limbal tissues combined with
AM
A total of 15 studies were selected for the analysis of the
outcome of CLAU or CLAL (Table 2). No notable difference
was reported between CLAU and CLAU combined with
AMT, but there was a greater re-epithelization time when
AMT was used alone. AMT is being actively used as a
common procedure in direct limbal tissue transplantation
for its healing properties and to increase graft survival
rate.
